BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12606295)

  • 1. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
    Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA; O'Mara DJ; Brockel BJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
    Haberny SL; Carr KD
    Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
    Peleg-Raibstein D; Feldon J
    Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME; Lasley SM
    Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study.
    Hong SK; Jung IS; Bang SA; Kim SE
    Neurosci Lett; 2006 Dec; 409(3):220-3. PubMed ID: 17046158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization to amphetamine occurs simultaneously at immune level and in met-enkephalin of the nucleus accumbens and spleen: an involved NMDA glutamatergic mechanism.
    Assis MA; Hansen C; Lux-Lantos V; Cancela LM
    Brain Behav Immun; 2009 May; 23(4):464-73. PubMed ID: 19486656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity.
    Cory-Slechta DA
    Neurotoxicology; 1997; 18(3):673-88. PubMed ID: 9339816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
    Filip M; Papla I; Nowak E; Jungersmith K; Przegaliński E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats.
    Murray F; Harrison NJ; Grimwood S; Bristow LJ; Hutson PH
    Eur J Pharmacol; 2007 May; 562(3):191-7. PubMed ID: 17321516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
    Zuch CL; O'Mara DJ; Cory-Slechta DA
    Toxicol Appl Pharmacol; 1998 May; 150(1):174-85. PubMed ID: 9630467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning versus performance impairments following regional administration of MK-801 into nucleus accumbens and dorsomedial striatum.
    Cory-Slechta DA; O'Mara DJ; Brockel BJ
    Behav Brain Res; 1999 Jul; 102(1-2):181-94. PubMed ID: 10403026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
    Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
    Farrar AM; Segovia KN; Randall PA; Nunes EJ; Collins LE; Stopper CM; Port RG; Hockemeyer J; Müller CE; Correa M; Salamone JD
    Neuroscience; 2010 Apr; 166(4):1056-67. PubMed ID: 20096336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different function of pedunculopontine GABA and glutamate receptors in nucleus accumbens dopamine, pedunculopontine glutamate and operant discriminative behavior.
    Steiniger-Brach B; Kretschmer BD
    Eur J Neurosci; 2005 Oct; 22(7):1720-30. PubMed ID: 16197512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.